Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Arc-1 vs Rewinding RX

Arc-1
Graded #417

Lower grade

vs+3.200000000000003
Rewinding RX
Graded #340

Higher grade

The verdict

Rewinding RX takes it — 59.5/100 to 56.3/100.

Rewinding RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Rewinding RX is a longevity-focused telehealth platform that frames compounded GLP-1 therapy within a broader biological-age-reversal program alongside NAD+ and functional-medicine protocols.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRewinding RX +1
44
45
Dose & formulationArc-1 +14
54
40
Clinical oversightRewinding RX +13
72
85
Labs & monitoringRewinding RX +1
52
53
FulfillmentRewinding RX +25
62
87
Contract termsEven
61
61
Arc-1 · left barRewinding RX · right bar

The numbers

MetricArc-1Rewinding RX
WeighScore56.3/10059.5/100
GradeCC
Scorecard rank#417#340
Semaglutide$200/mo (0.5 mg dose, compounded)Not disclosed
Tirzepatide$200/mo (2.5 mg dose, compounded)Not disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Arc-1

Graded #417 · C

Strengths

  • Both compounded semaglutide and tirzepatide available
  • Per-dose purchasing — no subscription or membership required
  • 25% off plus free shipping promotion
  • Broader longevity formulary (rapamycin, NAD+, sermorelin)
  • LegitScript Certified badge now displayed on product pages

Where it loses points

  • No legal entity name or address disclosed
  • State availability not disclosed
  • No named clinicians or pharmacy partners
  • Per-dose pricing still climbs with dose (semaglutide 2.5mg is $549.99/mo, tirzepatide 7.5mg $399.99/mo)
Rewinding RX

Graded #340 · C

Strengths

  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer — uncommon transparency
  • MD-only physician network ('never a physician assistant or nurse')
  • All-50-state coverage with physician state-licensing matching
  • Corporate entity disclosed (Rewinding RX Ltd.)

Where it loses points

  • Pricing not shown — fully gated behind sign-up
  • Pharmacy partner not named (only generic 503A/503B references)
  • Medical director / clinical leadership not disclosed
  • Governing law, arbitration venue, and corporate address not disclosed
  • Tirzepatide not listed on the homepage (semaglutide only confirmed)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard